Your browser doesn't support javascript.
loading
Bioorthogonal site-selective conjugation of fluorescent dyes to antibodies: method and potential applications.
Grossenbacher, Philipp; Essers, Maria C; Moser, Joël; Singer, Simon A; Häusler, Stephanie; Stieger, Bruno; Rougier, Jean-Sébastien; Lochner, Martin.
Afiliação
  • Grossenbacher P; Institute of Biochemistry and Molecular Medicine, University of Bern Bühlstrasse 28 3012 Bern Switzerland martin.lochner@ibmm.unibe.ch.
  • Essers MC; Institute of Biochemistry and Molecular Medicine, University of Bern Bühlstrasse 28 3012 Bern Switzerland martin.lochner@ibmm.unibe.ch.
  • Moser J; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern Freiestrasse 3 3012 Bern Switzerland.
  • Singer SA; Institute of Biochemistry and Molecular Medicine, University of Bern Bühlstrasse 28 3012 Bern Switzerland martin.lochner@ibmm.unibe.ch.
  • Häusler S; Department of Clinical Pharmacology and Toxicology, University Hospital Zürich, University of Zürich Rämistrasse 100 8091 Zürich Switzerland.
  • Stieger B; Department of Clinical Pharmacology and Toxicology, University Hospital Zürich, University of Zürich Rämistrasse 100 8091 Zürich Switzerland.
  • Rougier JS; Institute of Biochemistry and Molecular Medicine, University of Bern Bühlstrasse 28 3012 Bern Switzerland martin.lochner@ibmm.unibe.ch.
  • Lochner M; Institute of Biochemistry and Molecular Medicine, University of Bern Bühlstrasse 28 3012 Bern Switzerland martin.lochner@ibmm.unibe.ch.
RSC Adv ; 12(44): 28306-28317, 2022 Oct 04.
Article em En | MEDLINE | ID: mdl-36320493
ABSTRACT
Antibodies are immensely useful tools for biochemical research and have found application in numerous protein detection and purification methods. Moreover, monoclonal antibodies are increasingly utilised as therapeutics or, conjugated to active pharmaceutical ingredients, in targeted chemotherapy. Several reagents and protocols are reported to synthesise fluorescent antibodies for protein target detection and immunofluorescence applications. However, most of these protocols lead to non-selective conjugation, over-labelling or in the worst case antigen binding site modification. Here, we have used the antibody disulphide cleavage and re-bridging strategy to introduce bright fluorescent dyes without loss of the antibody function. The resulting fluorescent IgG1 type antibodies were shown to be effective imaging tools in western blot and direct immunofluorescence experiments.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article